ARIANA YEA: Open Payments
NPI 1265156483 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,147 in 205 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $5,147
Food & beverage: $5,037Education: $110
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 33 | $907 |
| Teva Pharmaceuticals USA, Inc. | 26 | $696 |
| Janssen Pharmaceuticals, Inc | 11 | $518 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $465 |
| ABBVIE INC. | 15 | $459 |
| Vanda Pharmaceuticals Inc. | 17 | $431 |
| E.R. Squibb & Sons, L.L.C. | 22 | $399 |
| Alkermes, Inc. | 15 | $318 |
| Otsuka America Pharmaceutical, Inc. | 11 | $264 |
| Lundbeck LLC | 11 | $219 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, SPRAVATO, AUSTEDO XR, FANAPT, REXULTI, COBENFY.
Industry payments across CA — which companies pay providers there.
